Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women

Tekijä Sabbaj, Steffanie, Pass, Robert F., Goepfert, Paul A., Pichon, Sylvie
Julkaistu 2011

1113 Safety and Efficacy of a Cytomegalovirus Glycoprotein B (gB) Vaccine in Adolescent Girls

Tekijä Bernstein, David I., Callahan, S. Todd, Munoz-Rivas, Flor, Rupp, Rick, Edwards, Kathryn, Stanberry, Lawrence R., Pichon, Sylvie, Amegashie, Cyrille, Bellamy, Abbie R.
Julkaisussa Open Forum Infect Dis (2014)

Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantation

Tekijä Baraniak, Ilona, Gomes, Ariane C., Sodi, Isabella, Langstone, Toby, Rothwell, Emily, Atkinson, Claire, Pichon, Sylvie, Piras-Douce, Fabienne, Griffiths, Paul D., Reeves, Matthew B.
Julkaisussa EBioMedicine (2019)

Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia

Tekijä Baraniak, Ilona, Kropff, Barbara, McLean, Gary R, Pichon, Sylvie, Piras-Douce, Fabienne, Milne, Richard S B, Smith, Colette, Mach, Michael, Griffiths, Paul D, Reeves, Matthew B
Julkaisussa J Infect Dis (2018)

Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies

Tekijä Baraniak, Ilona, Kropff, Barbara, Ambrose, Lyn, McIntosh, Megan, McLean, Gary R., Pichon, Sylvie, Atkinson, Claire, Milne, Richard S. B., Mach, Michael, Griffiths, Paul D., Reeves, Matthew B.
Julkaisussa Proc Natl Acad Sci U S A (2018)

Safety and Efficacy of a Cytomegalovirus Glycoprotein B (gB) Vaccine in Adolescent Girls: a Randomized Clinical Trial

Tekijä Bernstein, David I., Munoz, Flor M., Callahan, S. Todd, Rupp, Richard, Wootton, Susan H., Edwards, Kathryn M., Turley, Christine B., Stanberry, Lawrence R., Patel, Shital M., Mcneal, Monica M., Pichon, Sylvie, Amegashie, Cyrille, Bellamy, Abbie R
Julkaisussa Vaccine (2015)

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

Tekijä Griffiths, Paul D, Stanton, Anna, McCarrell, Erin, Smith, Colette, Osman, Mohamed, Harber, Mark, Davenport, Andrew, Jones, Gareth, Wheeler, David C, O'Beirne, James, Thorburn, Douglas, Patch, David, Atkinson, Claire E, Pichon, Sylvie, Sweny, Paul, Lanzman, Marisa, Woodford, Elizabeth, Rothwell, Emily, Old, Natasha, Kinyanjui, Ruth, Haque, Tanzina, Atabani, Sowsan, Luck, Suzanne, Prideaux, Steven, Milne, Richard SB, Emery, Vincent C, Burroughs, Andrew K
Julkaistu 2011